Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
The STRIPE program funds pre-clinical research exploring how radiopharmaceutical therapy (RPT) impacts cancer biology, focusing on normal tissue, tumor cells, and the tumor microenvironment. Successful projects will test hypotheses about RPT's dynamic effects on cancer processes, with the goal of informing new targeting strategies and RPT-based clinical trials.
The STRIPE program seeks to support pre-clinical research projects utilizing state-of-the-art cancer biology methods and model systems that study how radiopharmaceutical therapy (RPT) agents affect the biology of normal tissue, tumor cells and the tumor microenvironment. Ideally, proposed aims …
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers